Skip to main content
TipRanks
Go Ultimate75% OFF

GenMont Biotech, Inc. (3164) Balance Sheet

GenMont Biotech, Inc. Balance Sheet

GenMont Biotech, Inc.'s total assets for Q2 2026 were NT$1.67B, a decrease of 1.87% from the previous quarter. TW:3164 total liabilities were NT$241.98M for the fiscal quarter, a 18.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 1.67BNT$ 1.71BNT$ 1.65BNT$ 1.70BNT$ 1.70B
NT$ 215.35MNT$ 229.06MNT$ 204.06MNT$ 198.59MNT$ 173.65M
NT$ 1.45BNT$ 1.48BNT$ 1.45BNT$ 1.50BNT$ 1.52B

Currency in TWD

GenMont Biotech, Inc. Liabilities to Assets

0600M1.2B1.8B4 %8 %12 %16 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets